
|Videos|August 24, 2017
Dr. Campbell on the Future of the Management of RCC
Author(s)Steven Campbell, MD, PhD
Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses the future of the treatment management for patients with renal cell carcinoma (RCC).
Advertisement
Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses the future of the treatment management for patients with renal cell carcinoma (RCC).
In the future, researchers hope to see an increased utilization of partial nephrectomy and a more sensible utilization of radical nephrectomy, states Campbell.
Many are advocating for a utility-based approach to renal mass biopsy, meaning it will only be applied to patients who might have their treatment management changed, explains Campbell.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer
2
NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer
3
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
4
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
5



































